Allo HSCT for High Risk Hemoglobinopathies

Clinical trial NCT06872333 · RECRUITING

Trial details

NCT number: NCT06872333
Sponsor: Masonic Cancer Center, University of Minnesota
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Failure Sickle Cell Disease Hemoglobinopathies

Start date: 2024-11-19
Primary completion: 2030-06-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.